IQV vs ORCL
IQV: IQVIA is a global leader in clinical research and healthcare data analytics that powers the development and commercialization of life-saving medical treatments. ORCL: A global leader in enterprise cloud computing, database management, and business applications powering mission-critical infrastructure for large-scale organizations.
Side-by-side fundamentals
| Metric | IQV | ORCL | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $213.22 | $119.90 | |
| Market cap as of 2026-07-29 | $40.5B | $345.4B | |
| P/E as of 2026-07-29 | 26.42 | 20.46 | ORCL lower |
| PEG as of 2026-07-29 | 2.66 | 1.04 | ORCL lower |
| Net margin as of 2026-07-29 | +8.3% | +25.4% | ORCL higher |
| Gross margin as of 2026-07-29 | +33.0% | +65.8% | ORCL higher |
| Operating margin as of 2026-07-29 | +13.2% | +30.6% | ORCL higher |
| ROE as of 2026-07-29 | +22.5% | +50.4% | ORCL higher |
| ROA as of 2026-07-29 | +4.7% | +7.7% | ORCL higher |
| Debt / equity as of 2026-07-29 | 2.55 | 3.01 | IQV lower |
| Revenue growth (YoY) as of 2026-07-29 | +7.3% | +17.4% | ORCL higher |
| Revenue CAGR (3y) SEC XBRL | +4.2% | +10.5% | ORCL higher |
| Dividend yield as of 2026-07-29 | n/a | +1.7% | |
| Dividend streak (yrs) SEC XBRL | 1 | 5 | ORCL higher |
| Beta as of 2026-07-29 | 1.16 | 1.74 | |
| 1-year return as of 2026-07-27 close | +7.1% | -51.1% | IQV higher |
Fundamentals: Finnhub, as of 2026-07-29. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.